Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Women's Health Reviews
  4. Volume 21, Issue 3
  5. Article
Volume 21, Issue 3
  • ISSN: 1573-4048
  • E-ISSN: 1875-6581

Abstract

Introduction

Ovarian cancers are the third most common gynecological and 8th most common cancer in women, associated with high mortality rates globally.

Case Presentation

A 60-year-old postmenopausal woman presented to the Gynecological outpatient department with complaints of pain in the abdomen for 2-3 months and loss of appetite with weight loss for 1-2 months. She was diagnosed as a case of uterine leiomyosarcoma or left adnexal mass on ultrasound and MRI. Intra-operatively, she was diagnosed with a unilateral left ovarian malignant mass, predominantly solid in consistency with metastasis to the left fallopian tube, uterus, cervical stroma, and omentum. The right ovary and tube were healthy. On histopathological examination, the final diagnosis of primary mucinous ovarian carcinoma was made. The patient tolerated staging laparotomy (total abdominal hysterectomy with bilateral salpingo-oophorectomy and infracolic omentectomy) well and was started on six cycles of adjuvant chemotherapy with Paclitaxel and Carboplatin injections along with Bevacizumab.

Conclusion

Primary mucinous ovarian carcinomas are rare and distinct subtypes of epithelial ovarian carcinomas. Due to their strong resemblance to other ovarian tumors and leiomyosarcoma, their diagnosis becomes challenging. Hence, it is crucial to consider leiomyosarcomas in the differential diagnosis of ovarian masses, especially in postmenopausal women.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cwhr/10.2174/0115734048299563240318061151
2024-03-20
2024-12-23

  • From This Site

    /content/journals/cwhr/10.2174/0115734048299563240318061151
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Cancer stat facts: Ovarian cancer.2023Available from: https://seer.cancer.gov/statfacts/html/ovary.html
  2. BabaierA. GhatageP. Mucinous cancer of the ovary: Overview and current status.Diagnostics20201015210.3390/diagnostics1001005231963927
     [Google Scholar]
  3. KurnitK.C. FrumovitzM. Primary mucinous ovarian cancer: Options for surgery and chemotherapy.Int. J. Gynecol. Cancer202232111455146210.1136/ijgc‑2022‑00380636229081
     [Google Scholar]
  4. CheasleyD. WakefieldM.J. RylandG.L. The molecular origin and taxonomy of mucinous ovarian carcinoma.Nat. Commun.2019101393510.1038/s41467‑019‑11862‑x31477716
     [Google Scholar]
  5. ChauhanS.C. KumarD. JaggiM. Mucins in ovarian cancer diagnosis and therapy.J. Ovarian Res.2009212110.1186/1757‑2215‑2‑2120034397
     [Google Scholar]
  6. DundrP. SinghN. NožičkováB. NěmejcováK. BártůM. StružinskáI. Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: A review of current problematics.Diagn. Pathol.20211612010.1186/s13000‑021‑01079‑233706757
     [Google Scholar]
  7. AngelinaY.A. TjokroprawiroB.A. Advanced stage clear cell ovarian carcinoma mimicking uterine sarcoma without gross residual tumor during primary surgery: A case report.Clin. Med. Insights Case Rep.20231610.1177/1179547623116662337056468
     [Google Scholar]
  8. SimonsM. BolhuisT. De HaanA.F. A novel algorithm for better distinction of primary mucinous ovarian carcinomas and mucinous carcinomas metastatic to the ovary.Virchows Arch.2019474328929610.1007/s00428‑018‑2504‑030631934
     [Google Scholar]
  9. DundrP. BártůM. BosseT. Primary mucinous tumors of the ovary: An interobserver reproducibility and detailed molecular study reveals significant overlap between diagnostic categories.Mod. Pathol.202336110004010.1016/j.modpat.2022.10004036788074
     [Google Scholar]
  10. ParkC.K. KimH.S. Clinicopathological characteristics of ovarian metastasis from colorectal and pancreatobiliary carcinomas mimicking primary ovarian mucinous tumor.Anticancer Res.20183895465547310.21873/anticanres.1287930194204
     [Google Scholar]
  11. LeeS. SungJ.A. JungM. KimH. LeeC. Prognosis in primary mucinous ovarian carcinoma: Focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary.J. Gynecol. Oncol.2022332e1810.3802/jgo.2022.33.e1834910399
     [Google Scholar]
  12. MoriceP. GouyS. LearyA. Mucinous ovarian carcinoma.N. Engl. J. Med.2019380131256126610.1056/NEJMra181325430917260
     [Google Scholar]
  13. SchiavoneM.B. HerzogT.J. LewinS.N. Natural history and outcome of mucinous carcinoma of the ovary.Am. J. Obstet. Gynecol.20112055480.e1480.e810.1016/j.ajog.2011.06.04921861962
     [Google Scholar]
  14. BrownJ. FrumovitzM. Mucinous tumors of the ovary: Current thoughts on diagnosis and management.Curr. Oncol. Rep.201416638910.1007/s11912‑014‑0389‑x24777667
     [Google Scholar]
  15. KaramurzinY.S. KiyokawaT. ParkashV. Gastric-type endocervical adenocarcinoma.Am. J. Surg. Pathol.201539111449145710.1097/PAS.000000000000053226457350
     [Google Scholar]
  16. LuJ. NaJ. LiY. WangX. WangJ. HanS. Gastric-type mucinous endocervical adenocarcinomas: A case report and literature review.Front. Cell. Infect. Microbiol.20221291700910.3389/fcimb.2022.91700936310872
     [Google Scholar]
  17. SchmelerK.M. TaoX. FrumovitzM. Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary.Obstet. Gynecol.2010116226927310.1097/AOG.0b013e3181e7961d20664385
     [Google Scholar]
  18. LertkhachonsukA. BuranawongtrakoonS. LekskulN. RermlukN. Wee-SteklyW.W. CharakornC. Serum CA19 ‐9, CA ‐125 and CEA as tumor markers for mucinous ovarian tumors.J. Obstet. Gynaecol. Res.202046112287229110.1111/jog.1442732830422
     [Google Scholar]
  19. KhameneS.S. KhawajahM.I. MahboobipourA.A. The role of CA19-9 and CA125 in differentiation of ovarian dermoid cyst and ovarian malignancy: A case-control study. Fertility.Gynecology and Andrology202331e13714410.5812/fga‑137144
     [Google Scholar]
  20. CraigO. SalazarC. GorringeK.L. Options for the treatment of mucinous ovarian carcinoma.Curr. Treat. Options Oncol.2021221211410.1007/s11864‑021‑00904‑634773517
     [Google Scholar]
  21. SiarkouM.C. PetousisS. PapanikolaouA. Neoadjuvant chemotherapy in advanced-stage ovarian cancer – State of the art.Przegl. Menopauz.202221427227510.5114/pm.2022.12401836704762
     [Google Scholar]
  22. SatohT. HataeM. WatanabeY. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: A proposal for patient selection.J. Clin. Oncol.201028101727173210.1200/JCO.2009.24.861720194858
     [Google Scholar]
  23. ParkJ.Y. KimD.Y. SuhD.S. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: Oncologic safety and reproductive outcomes.Gynecol. Oncol.2008110334535310.1016/j.ygyno.2008.04.04018586310
     [Google Scholar]
  24. LiJ. QiaoH. LiuY. Safety of fertility-sparing surgery in young women with stage I endometrioid epithelial and mucinous ovarian cancer: A population-based analysis.Eur. J. Surg. Oncol.202450110727610.1016/j.ejso.2023.10727638064863
     [Google Scholar]
  25. LeeJ.Y. JoY.R. KimT.H. Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary.Cancer Res. Treat.201547229030510.4143/crt.2014.00425287480
     [Google Scholar]
  26. GulloG. PerinoA. CucinellaG. Open vs. closed vitrification system: Which one is safer?Eur. Rev. Med. Pharmacol. Sci.20222641065106710.26355/eurrev_202202_2809235253158
     [Google Scholar]
  27. GiampaolinoP. CafassoV. BocciaD. Fertility-sparing approach in patients with endometrioid endometrial cancer grade 2 stage IA (FIGO): A qualitative systematic review.BioMed Res. Int.2022202211510.1155/2022/407036836203482
     [Google Scholar]
  28. MutluL. ManavellaD.D. GulloG. McNamaraB. SantinA.D. PatrizioP. Endometrial cancer in reproductive age: Fertility-sparing approach and reproductive outcomes.Cancers20221421518710.3390/cancers1421518736358604
     [Google Scholar]
  29. GulloG. CucinellaG. ChianteraV. Fertility-sparing strategies for early-stage endometrial cancer: Stepping towards precision medicine based on the molecular fingerprint.Int. J. Mol. Sci.202324181110.3390/ijms2401081136614253
     [Google Scholar]
  30. PiergentiliR. GulloG. BasileG. Circulating miRNAs as a tool for early diagnosis of endometrial cancer—implications for the fertility-sparing process: Clinical, biological, and legal aspects.Int. J. Mol. Sci.202324141135610.3390/ijms24141135637511115
     [Google Scholar]
/content/journals/cwhr/10.2174/0115734048299563240318061151
Loading
A Complex Case: Solid Unilateral Ovarian Mucinous Carcinoma Masquerading as Leiomyosarcoma in Postmenopausal Women
Current Women's Health Reviews 21, E200324228143 (2025); https://doi.org/10.2174/0115734048299563240318061151
/content/journals/cwhr/10.2174/0115734048299563240318061151
/content/journals/cwhr/10.2174/0115734048299563240318061151
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): Leiomyosarcoma; leiomyosarcomas; metastasis; mucinous carcinoma; ovary; uterus

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test